Home » Newsletters » BioWorld

BioWorld

Sep. 6, 1991

View Archived Issues

MARROW-TECH TO USE SBIR FOR DERMAGRAFT RESEARCH

THERATECH TO COLLABORATE WITH SYNTEX

CAMBRIDGE NEURO SBIR FOR HEART SURGERY COMPOUND

BIOCRYST GETS SBIR FOR FLU TREATMENT

LIDAK GETS SBIR FOR FREE FATTY ACID ASSAY

IMMUNOGEN STARTS EUROPEAN CLINICALS

CYTEL INVESTIGATES WHITE CELLS AND TARGETS

GM-CSF ALTERNATIVE TO BONE MARROW TRANSPLANT

CENTOXIN LABEL MAY DETERMINE MARKET SIZE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...